Cargando…
Role of oxaliplatin in the treatment of colorectal cancer
Oxaliplatin is a third-generation platinum compound that has shown a definite role in the management of colorectal cancer (CRC). Oxaliplatin in combination with fluorouracil and leucovorin in the FOLFOX4 regimen represents a new standard of treatment in the adjuvant setting as well as for the metast...
Autores principales: | Comella, Pasquale, Casaretti, Rossana, Sandomenico, Claudia, Avallone, Antonio, Franco, Luca |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697505/ https://www.ncbi.nlm.nih.gov/pubmed/19436599 |
Ejemplares similares
-
Oxaliplatin plus raltitrexed and leucovorin-modulated 5-fluorouracil i.v. bolus: a salvage regimen for colorectal cancer patients
por: Comella, P, et al.
Publicado: (2002) -
A review of the role of capecitabine in the treatment of colorectal cancer
por: Comella, Pasquale
Publicado: (2007) -
Heterogeneous disease and intermittent treatment in metastatic colorectal cancer: A case report
por: De Stefano, Alfonso, et al.
Publicado: (2023) -
Randomized phase II study of valproic acid in combination with bevacizumab and oxaliplatin/fluoropyrimidine regimens in patients with RAS-mutated metastatic colorectal cancer: the REVOLUTION study protocol
por: Avallone, Antonio, et al.
Publicado: (2020) -
First Biologic Drug in the Treatment of RAS Wild-Type Metastatic Colorectal Cancer: Anti-EGFR or Bevacizumab? Results From a Meta-Analysis
por: Ottaiano, Alessandro, et al.
Publicado: (2018)